Last close As at 05/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: Financials
Scherzer’s (PZS) NAV at end August 2020 increased by 12.6% ytd, ahead of German equity markets, which were roughly flat compared to end FY19. The main NAV uplift came from profit derived from the ECS portfolio and Audi’s squeeze-out price announcement. The impact of PZS’s portfolio management on its P&L was only marginally positive, as valuations remain depressed and companies reduce dividends in uncertain times. Under current accounting standards, PZS’s NAV growth may lag that of the broader market until investments are realized. Also, a significant part of the portfolio is ‘locked’ in anticipation of squeeze-outs, which on execution will have a positive impact on the P&L and enhance the ECS portfolio.
Scherzer & Co |
Successful conclusion of AXA case
Asset management |
Scale research report - Update
8 September 2020 |
Share price graph
Share details
Business description
Bull
Bear
Analysts
|
||||||||||||||||||||||||||||
Scherzer’s (PZS) NAV at end August 2020 increased by 12.6% ytd, ahead of German equity markets, which were roughly flat compared to end FY19. The main NAV uplift came from profit derived from the ECS portfolio and Audi’s squeeze-out price announcement. The impact of PZS's portfolio management on its P&L was only marginally positive, as valuations remain depressed and companies reduce dividends in uncertain times. Under current accounting standards, PZS’s NAV growth may lag that of the broader market until investments are realized. Also, a significant part of the portfolio is ‘locked’ in anticipation of squeeze-outs, which on execution will have a positive impact on the P&L and enhance the ECS portfolio.
AXA rights sold for an €8.5m profit
During H120, PZS sold one of its largest ECS positions in AXA. The transaction resulted in a €9.1m cash inflow and €8.5m positive P&L impact, part of which was recognised in interest income. Consequently, PZS’s ECS portfolio decreased to €113m (from €139m at end FY19). The ECS portfolio is likely to be enlarged through new transactions, as squeeze-outs are expected in some of the largest positions, eg Audi (15.9% of the portfolio) and MAN (9.2%). While ECS results are highly uncertain, we note that the initial squeeze-out proceeds can be reinvested in currently volatile markets.
Muted trading result and dividend income in H120
During H120 PZS’s NAV increased by 7.4% compared to a 7.8% decrease by the SDAX in total return (TR) terms. While the EPS of €0.09 was achieved mostly on the AXA case, PZS also reported a €0.9m profit on active trading in stocks. However, unrealized losses on held positions stood at €4.9m and income from dividends declined by 80% as many companies decided to refrain from or delay dividend payments (in some cases due to postponed AGMs) given the current economic climate. PZS ended H120 with €2.3m in cash (FY19: €0.7m) and a net debt to equity ratio at 34% – in line with the long-term average.
Valuation: Share price lagging NAV growth
PZS’s shares have been trading close to par over recent years, which we believe stems from the ‘hidden value’ of the ECS portfolio, which is not included in the NAV. Strong support from the AXA ECS disposal was recognized in June and as the share price did not increase accordingly, PZS’s discount now stands at 11%.
|
Consensus estimates
Source: Scherzer & Co, Refinitiv consensus based on three analysts at 8 September 2020. |
Edison Investment Research provides qualitative research coverage on companies in the Deutsche Börse Scale segment in accordance with section 36 subsection 3 of the General Terms and Conditions of Deutsche Börse AG for the Regulated Unofficial Market (Freiverkehr) on Frankfurter Wertpapierbörse (as of 1 March 2017). Two to three research reports will be produced per year. Research reports do not contain Edison analyst financial forecasts.
Financials: ECS disposal driving profits
PZS reported €2.7m net income (EPS of €0.09) in H120, which was achieved in a volatile pricing environment for public assets and compares to break-even in H119. The largest profit was realized on PZS’s ECS portfolio, where the disposal of AXA rights represented a major part of the €5.7m gain from ECS (with no major cases in H119). The result loss on realized transactions amounted to €0.1m (H119: €0.9m gain), as the €0.9m gain on equities (H119: €0.6m) was offset by a €1.0m loss on derivatives. Consequently, the result on financial instruments was €5.7m vs €1.0m in H119. Meanwhile, overall weak macroeconomic conditions weighed on the portfolio valuation. Unrealized downward value changes on held positions amounted to €4.9m (H119: €1.4m), which, paired with lower income from dividends and higher operating costs led to an EBIT loss to the tune of €0.4m (€0.4m profit in H119). Other operating costs increased to €1.1m from €0.4m in H119 on the back of higher legal and consulting costs. The disposal of AXA rights also resulted in financial income (through the recognition of interest accrued on the claim) contributing to H120 net financial income of €3.4m (H119: -€0.1m).
ECSs are claims relating to companies that have performed a squeeze-out at their listed subsidiaries where PZS was a minority shareholder. PZS attempts to prove in court that a squeeze-out was performed at a price below fair value and receives compensation if successful. In the AXA situation, the squeeze-out was performed in 2006 at €144.68 per ordinary share, and in August 2019 the first ruling set the fair value of the shares at the time at €177.58. In June 2020, PZS sold its claims against AXA to a third party before the final ruling, receiving €9.1m in cash, and recognized an €8.5m profit (split between gain on disposal and ‘interests and similar income’).
PZS ended H120 with €2.3m in cash (FY19: €0.7m) which, together with €21.5m financial debt, implies a net debt position of €19.3m, down from €22.6m at end-FY19. The net debt to equity ratio decreased to 34% from 42% at end-FY19, which is in line with PZS’s long-term average of 38%.
Exhibit 1: FY19 results highlights
€000s, unless otherwise stated |
H120 |
H119 |
y-o-y |
Gains from financial instruments |
9,950 |
2,193 |
339% |
Losses from financial instruments |
(4,280) |
(1,226) |
249% |
Result on financial instruments |
5,670 |
967 |
446% |
Other operating income (excluding value adjustments) |
10 |
33 |
N/M |
Personnel expenses |
(336) |
(308) |
9% |
Other operating expenses |
(1,104) |
(363) |
204% |
Income from dividends |
320 |
1,524 |
(79%) |
Unrealized gains (losses) |
(4,935) |
(1,434) |
244% |
D&A |
0 |
(8) |
N/M |
EBIT |
(374) |
410 |
N/M |
Other interest and similar income |
3,465 |
51 |
6738% |
Interest and similar expenses |
(93) |
(109) |
(15%) |
EBT |
2,998 |
351 |
753% |
Income and other taxes |
(235) |
(342) |
(31%) |
Net profit for the period |
2,763 |
9 |
N/M |
EPS (€) |
0.09 |
0.00 |
N/M |
Source: Scherzer & Co accounts, Edison Investment Research
PZS’s end-August 2020 NAV per share was €2.59 (based on market values), which implies a 12.6% ytd return. This represents strong outperformance vs German equity indices, with the DAX posting a 2.3% fall in TR terms over the period. The growth was strongly supported by the 26.7% m-o-m return (or €0.52 accretion per share) in June, when PZS booked €8.5m in income from the favourable AXA ruling. Additionally, its major portfolio component, Audi, had posted a 52% share price rally. We calculate that Audi’s price performance in June contributed c 6.5pp to ytd NAV performance. PZS’s share price rebounded more moderately, which resulted in a widened discount to NAV. While the ECS portfolio is not included in NAV, the successful closures support NAV through realized gains. After deducting €25.6m in AXA shares, the ECS portfolio stood at €113m at end August 2020 (€105m excluding ECSs held by portfolio companies). As a reminder, the ECS portfolio is presented at the initial value received under squeeze-outs and other corporate actions, and is not adjusted for developments in legal proceedings until conclusion.
We note that PZS’s portfolio development is not fully reflected on its income statement and balance sheet. Under German reporting standards, a decrease in the market price of a portfolio holding is reflected in write-offs, while the company can only report positive value adjustments by reversing write-offs and, in effect, the book value of the portfolio cannot exceed the initial investment unless the holding is sold. This includes Audi’s recent price performance.
|
Exhibit 2: PZS’s NAV per share and share price comparison (€) |
|
|
Source: Scherzer & Co accounts |
Portfolio developments
Scherzer specialises in investing in undervalued companies, which management believes comes from a lack of understanding by the general market. Its targets are stocks with little to no research coverage, business models that are difficult to evaluate or companies in special situations such as restructuring or M&A. PZS structures its portfolio in two categories: ‘safe’, which consists of companies with high asset quality and sustainable earnings (including squeeze-out candidates), and ‘opportunistic’ with companies in other special situations, growth stocks and those with disruptive business models. At end H120, 54% of PZS’s portfolio was classified as safe (FY19: 36%).
Scherzer’s portfolio is relatively condensed, with 10 holdings representing 64% of the portfolio at end August 2020. Audi remains the largest holding, making up 16% of the portfolio. On 31 July 2020, Audi’s AGM approved the squeeze-out by Volkswagen at the price of €1,551 per share (while at end FY19 the share price was €800). We calculate that on completion PZS will receive c €10m in proceeds and understand that the shares will increase PZS’s ECS portfolio. As a reminder, the recent Audi share price rally is not reflected in PZS’s income statement, and the profit will be recognised only on execution of the squeeze-out. Until then, 16% of PZS’s portfolio is ‘locked’ with limited deviation from the announced transaction price.
The second largest investment at end August 2020 is MAN, representing 9% of the portfolio. Scherzer significantly increased its holding in the company during May, after Traton (a subsidiary of Volkswagen, which holds a 94.4% stake in the company) confirmed its intention to squeeze out the remaining shareholders. While the final squeeze-out price has not yet been set, MAN’s share price increased by 33% following the announcement. We understand that the transaction will be included in PZS’s ECS portfolio.
The development of portfolio value is also affected by illiquid stocks trading on the OTC markets (eg Weleda and AG für Erstellung billiger Wohnhäuser in Winterthur), and majority-owned companies with adjacent business models (eg Horus).
Exhibit 3: PZS’s top 10 holdings list
Company |
% of total |
% of total |
Change (pp) |
Opportunistic/ |
Audi |
15.87% |
5.57% |
10.30 |
Safe |
MAN |
9.22% |
N/A |
N/A |
Safe |
GK Software |
8.49% |
10.21% |
(1.72) |
Opportunistic |
freenet |
7.96% |
8.12% |
(0.16) |
Opportunistic |
Allerthal-Werke |
4.60% |
4.79% |
(0.19) |
Safe |
ZEAL Network |
4.28% |
N/A |
N/A |
Opportunistic |
Weleda |
3.77% |
4.38% |
(0.61) |
Opportunistic |
Lotto24 |
3.67% |
N/A |
N/A |
Safe |
Horus |
3.03% |
3.87% |
(0.84) |
Opportunistic |
AG f. Erstellung billiger Wohnh. in Winterthur |
2.93% |
3.62% |
(0.69) |
Safe |
Total top-10 holdings |
63.82% |
50.22%* |
- |
- |
Source: Scherzer & Co, Edison Investment Research. Note: *Top 10 holdings as at end of August 2019.
Valuation
At the end of August 2020, PZS’s NAV per share stood at €2.59 and the current share price of €2.30 implies a 11.2% discount. For the three years before the COVID-induced sell-off, PZS shares traded at par on average (2017–19 average discount of 0.4%). The current discount may seem relatively high, but we should emphasise that the AXA case accounted for 20% of the ECS portfolio at end FY19 and its potential has already been realized. We calculate that disposal of the AXA rights amounted to €0.28 pre-tax profit per share, compared to overall post-tax EPS of €0.09 in H120.
PZS shares delivered a ytd return to 7 September of 5.5%, strongly outperforming German equity indices. The DAX, MDAX and SDAX delivered total returns between a 2.6% decrease (MDAX) and a 0.6% decrease (SDAX). PZS currently trades broadly in line with the market on a P/E ratio basis, at a FY20 premium of 11%, while historically it traded at close to a 50% discount. We believe this may stem from somewhat outdated consensus and not all contributors considering recent developments at AXA, as the mean estimate of FY20 EPS amounts to €0.06, ranging from a €0.06 loss to a €0.20 profit.
Exhibit 4: Comparable market P/E ratios (x)
2015 |
2016 |
2017 |
2018 |
2019 |
2020e |
2021e |
|
DAX |
22.0 |
19.0 |
14.6 |
12.9 |
22.7 |
21.5 |
15.3 |
MDAX |
19.2 |
28.8 |
17.6 |
13.4 |
26.1 |
42.0 |
25.4 |
SDAX |
28.0 |
23.5 |
23.4 |
13.8 |
32.1 |
40.1 |
16.8 |
Arithmetic average |
23.1 |
23.8 |
18.5 |
13.4 |
27.0 |
34.5 |
19.2 |
PZS |
9.2 |
13.6 |
10.0 |
loss |
loss |
38.3 |
14.4 |
PZS discount |
60% |
43% |
46% |
N/A |
N/A |
(11%) |
25% |
Source: Refinitiv at 7 September 2020, PZS reports. Note: PZS forecast is Refinitiv consensus based on three analysts. P/E ratios based on year-end prices, forward ratios based on current prices.
On a P/BV ratio, the narrowing of PZS's discount to the market has been apparent since 2015, reaching 13% at end 2018. However, recent performance has driven the discount to 28% on FY20e book value.
Exhibit 5: Comparable market P/BV ratios (x)
2015 |
2016 |
2017 |
2018 |
2019 |
2020e |
2021e |
|
DAX |
1.7 |
1.7 |
1.9 |
1.4 |
1.6 |
1.6 |
1.5 |
MDAX |
2.3 |
1.9 |
2.1 |
1.6 |
2.1 |
1.9 |
1.8 |
SDAX |
2.0 |
1.7 |
1.8 |
1.6 |
1.5 |
1.3 |
1.3 |
Arithmetic average |
2.0 |
1.8 |
1.9 |
1.5 |
1.7 |
1.6 |
1.5 |
PZS |
0.8 |
0.9 |
1.3 |
1.3 |
1.2 |
1.1 |
1.1 |
PZS discount |
60% |
49% |
32% |
13% |
30% |
28% |
29% |
Source: Refinitiv as at 7 September 26 August 2020, PZS reports. Note: PZS forecast is Refinitiv consensus based on three analysts. Historical P/BV ratios based on year-end prices, forward ratios based on current prices.
|
||||||||||||
Research: Industrials
The COVID-19 pandemic had an adverse impact on demand for most of Nabaltec’s products during Q220, with the European steel and automotive industries particularly badly affected. Management has taken steps to reduce costs, so, if write-downs totalling €2.1m are excluded, the group generated €1.7m EBIT during Q220.